AC Immune SA (ACIU) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $2.39, -2.45% vs the prior close of $2.45.
- Volume 126.85K shares, 0.6x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
ACIU dips 2.4% to $2.39, a 1-month low. Closed at $2.39, -2.45% vs the prior close of $2.45. Day range $2.38β$2.47, opened at $2.45.
ACIU daily analysis β what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 β ACIU dips 2.4% to $2.39, a 1-month low
- Closed at $2.39, -2.45% vs the prior close of $2.45. Day range $2.38β$2.47, opened at $2.45.
- Volume was 126.85K shares, 0.6x its 50-day average of 208.11K.
- Price is -9.5% vs its 50-day average ($2.64) and -14.1% vs its 200-day average ($2.78).
- 52-week range $2.10β$4.00; today's close sits at 15% of that range, 40.2% below the 52-week high.
Oct 15, 2026 β ACIU rises 2.1% to $2.45
- Closed at $2.45, +2.08% vs the prior close of $2.40. Day range $2.38β$2.46, opened at $2.43.
- Volume was 86.90K shares, 0.4x its 50-day average of 209.27K β lighter than usual.
- Price is -7.2% vs its 50-day average ($2.64) and -12.0% vs its 200-day average ($2.79).
- 52-week range $2.10β$4.00; today's close sits at 19% of that range, 38.7% below the 52-week high.
Oct 14, 2026 β ACIU ends flat (+0.0%) to $2.40, 5 down days in a row
- Closed at $2.40, +0.00% vs the prior close of $2.40. Day range $2.35β$2.41, opened at $2.37.
- Volume was 209.70K shares, 1.0x its 50-day average of 207.20K.
- Price is -8.9% vs its 50-day average ($2.64) and -14.0% vs its 200-day average ($2.79).
- 52-week range $2.10β$4.00; today's close sits at 16% of that range, 40.0% below the 52-week high.
- That makes 5 straight losses.
Oct 13, 2026 β ACIU dips 2.0% to $2.40, a 1-month low, 4 down days in a row
- Closed at $2.40, -2.04% vs the prior close of $2.45. Day range $2.39β$2.44, opened at $2.43.
- Volume was 194.90K shares, 0.9x its 50-day average of 205.66K.
- Price is -8.8% vs its 50-day average ($2.63) and -14.1% vs its 200-day average ($2.79).
- 52-week range $2.10β$4.00; today's close sits at 16% of that range, 40.0% below the 52-week high.
- That makes 4 straight losses.
Oct 12, 2026 β ACIU dips 2.0% to $2.45, a 1-month low, 3 down days in a row
- Closed at $2.45, -2.00% vs the prior close of $2.50. Day range $2.42β$2.50, opened at $2.50.
- Volume was 148.50K shares, 0.7x its 50-day average of 207.27K.
- Price is -6.8% vs its 50-day average ($2.63) and -12.4% vs its 200-day average ($2.80).
- 52-week range $2.10β$4.00; today's close sits at 19% of that range, 38.7% below the 52-week high.
- That makes 3 straight losses.
Oct 9, 2026 β ACIU dips 2.0% to $2.50, a 1-month low
- Closed at $2.50, -1.96% vs the prior close of $2.55. Day range $2.47β$2.59, opened at $2.55.
- Volume was 271.30K shares, 1.3x its 50-day average of 206.76K.
- Price is -4.7% vs its 50-day average ($2.62) and -10.7% vs its 200-day average ($2.80).
- 52-week range $2.10β$4.00; today's close sits at 21% of that range, 37.5% below the 52-week high.
Oct 8, 2026 β ACIU dips 0.8% to $2.55
- Closed at $2.55, -0.78% vs the prior close of $2.57. Day range $2.50β$2.61, opened at $2.57.
- Volume was 231.90K shares, 1.1x its 50-day average of 203.35K.
- Price is -2.7% vs its 50-day average ($2.62) and -9.0% vs its 200-day average ($2.80).
- 52-week range $2.10β$4.00; today's close sits at 24% of that range, 36.3% below the 52-week high.
Oct 7, 2026 β ACIU rises 2.0% to $2.57
- Closed at $2.57, +1.98% vs the prior close of $2.52. Day range $2.50β$2.59, opened at $2.52.
- Volume was 125.10K shares, 0.6x its 50-day average of 202.93K.
- Price is -1.8% vs its 50-day average ($2.62) and -8.4% vs its 200-day average ($2.81).
- 52-week range $2.10β$4.00; today's close sits at 25% of that range, 35.8% below the 52-week high.
Oct 6, 2026 β ACIU slides 7.0% to $2.52, 3 down days in a row
- Closed at $2.52, -7.01% vs the prior close of $2.71. Day range $2.51β$2.72, opened at $2.72.
- Volume was 277.80K shares, 1.4x its 50-day average of 199.99K.
- Price is -3.5% vs its 50-day average ($2.61) and -10.2% vs its 200-day average ($2.81).
- 52-week range $2.10β$4.00; today's close sits at 22% of that range, 37.0% below the 52-week high.
- That makes 3 straight losses.
Oct 5, 2026 β ACIU dips 0.6% to $2.71
- Closed at $2.71, -0.55% vs the prior close of $2.72. Day range $2.65β$2.74, opened at $2.68.
- Volume was 221.40K shares, 1.1x its 50-day average of 203.25K.
- Price is +4.0% vs its 50-day average ($2.61) and -3.5% vs its 200-day average ($2.81).
- 52-week range $2.10β$4.00; today's close sits at 32% of that range, 32.2% below the 52-week high.
Oct 2, 2026 β ACIU slides 3.0% to $2.72
- Closed at $2.72, -3.02% vs the prior close of $2.81. Day range $2.69β$2.88, opened at $2.84.
- Volume was 320.20K shares, 1.6x its 50-day average of 198.43K.
- Price is +4.9% vs its 50-day average ($2.60) and -3.1% vs its 200-day average ($2.81).
- 52-week range $2.10β$4.00; today's close sits at 33% of that range, 31.9% below the 52-week high.
- SEC filings that day: 6-K.
ACIU latest news & SEC filings
Every SEC filing by or about ACIU in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 9, 2026 Β· Form 3 β New insider holdings
Initial insider ownership statement (Form 3) β a new director, officer or 10% owner disclosed their holdings
Oct 2, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Sep 23, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Sep 3, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Aug 20, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Aug 11, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Aug 5, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Jun 30, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Things to know before you trade ACIU
- How much it moves: over the last 20 sessions the average daily move was 2.73% (largest 7.3%).
- Liquidity: about 217.91K shares (β$520.80K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $2.39 vs a range of $2.10β$4.00 (15% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 4 open-market buys, 8 sales; latest: Andrea Pfeifer sold 10,000 shares on May 15, 2026.
- Latest filings: 6-K Oct 2, 2026; 6-K Sep 23, 2026; 6-K Sep 3, 2026.
- Listing: Nasdaq Β· industry: Pharmaceutical Preparations.
ACIU market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 2.45 | 2.47 | 2.38 | 2.39 | 126.85K |
| Oct 15, 2026 | 2.43 | 2.46 | 2.38 | 2.45 | 86.90K |
| Oct 14, 2026 | 2.37 | 2.41 | 2.35 | 2.40 | 209.70K |
| Oct 13, 2026 | 2.43 | 2.44 | 2.39 | 2.40 | 194.90K |
| Oct 12, 2026 | 2.50 | 2.50 | 2.42 | 2.45 | 148.50K |
| Oct 9, 2026 | 2.55 | 2.59 | 2.47 | 2.50 | 271.30K |
| Oct 8, 2026 | 2.57 | 2.61 | 2.50 | 2.55 | 231.90K |
| Oct 7, 2026 | 2.52 | 2.59 | 2.50 | 2.57 | 125.10K |
| Oct 6, 2026 | 2.72 | 2.72 | 2.51 | 2.52 | 277.80K |
| Oct 5, 2026 | 2.68 | 2.74 | 2.65 | 2.71 | 221.40K |
| Oct 2, 2026 | 2.84 | 2.88 | 2.69 | 2.72 | 320.20K |
| Oct 1, 2026 | 2.64 | 2.84 | 2.57 | 2.81 | 352.70K |
| Sep 30, 2026 | 2.63 | 2.74 | 2.61 | 2.62 | 199.60K |
| Sep 29, 2026 | 2.65 | 2.66 | 2.56 | 2.60 | 134.20K |
| Sep 28, 2026 | 2.52 | 2.62 | 2.40 | 2.61 | 188.90K |
| Sep 25, 2026 | 2.66 | 2.66 | 2.45 | 2.52 | 323.60K |
| Sep 24, 2026 | 2.85 | 2.85 | 2.66 | 2.66 | 265.30K |
| Sep 23, 2026 | 2.90 | 2.91 | 2.67 | 2.83 | 491.80K |
| Sep 22, 2026 | 2.69 | 2.75 | 2.66 | 2.73 | 78.10K |
| Sep 21, 2026 | 2.63 | 2.72 | 2.57 | 2.65 | 109.40K |
About AC Immune SA
AC Immune SA (ACIU) is listed on the Nasdaq and classified by the SEC under βPharmaceutical Preparationsβ. Its business address is in 1015 LAUSANNE, Switzerland. State of incorporation: Switzerland. Fiscal year ends December 31. SEC CIK 1651625.
ACIU board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Renee Aguiar-Lucander | Director | Jun 15, 2026 |
| Monika Buetler | Director | Jun 15, 2026 |
| Carl Howard June | Director | Jun 15, 2026 |
| Andrea Pfeifer | Chief Executive Officer | May 18, 2026 |
| Roy Ervin Twyman | Director | Jun 15, 2026 |
| Martin Zuegel | Interim CEO | Jun 15, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Piergiorgio Donati | Chief Operating Officer | Mar 20, 2026 |
| Andrea Pfeifer | Chief Executive Officer | May 18, 2026 |
| Christopher James Roberts | Chief Financial Officer | Mar 18, 2026 |
| Martin Zuegel | Interim CEO | Jun 15, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| May 15, 2026 | Andrea Pfeifer | Sale | 10,000 | $2.79 |
| May 15, 2026 | Andrea Pfeifer | Sale | 10,000 | $2.79 |
| May 15, 2026 | Andrea Pfeifer | Sale | 10,000 | $2.79 |
| May 15, 2026 | Andrea Pfeifer | Sale | 10,000 | $2.79 |
| Apr 15, 2026 | Andrea Pfeifer | Buy | 10,000 | $3.14 |
| Apr 15, 2026 | Andrea Pfeifer | Buy | 10,000 | $3.14 |
| Apr 15, 2026 | Andrea Pfeifer | Buy | 10,000 | $3.14 |
| Apr 15, 2026 | Andrea Pfeifer | Buy | 10,000 | $3.14 |
| Apr 15, 2026 | Andrea Pfeifer | Sale | 10,000 | $3.14 |
| Apr 15, 2026 | Andrea Pfeifer | Sale | 10,000 | $3.14 |
| Apr 15, 2026 | Andrea Pfeifer | Sale | 10,000 | $3.14 |
| Apr 15, 2026 | Andrea Pfeifer | Sale | 10,000 | $3.14 |
ACIU financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $β, total liabilities $β, cash $β.
ACIU earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks Β· Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on ACIU
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.